Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04199 |
| Species: | Homo sapiens |
| Position : | chr1:98515300-98515700 |
| Year: | 2014 |
| Title: | A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Schizophrenia |
| PMID: | 25434007 |
| MONDO: | MONDO:0005090 |
| Tissue: | breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | MCF-7 |
| CVCL ID: | CVCL_0031 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; Chromatin interaction assay; Disease-variant functional analysis |
| High Throughput Method: | GWAS |
| Low Throughput Method: | Luciferase Reporter Assay; 3C |
| Target gene : | MIR137 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|